Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2003
10/23/2003WO2001047562A8 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199524 Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003US20030199497 Novel calcium receptor active molecules and method for preparing same
10/23/2003US20030199485 Novel anti-inflammatory androstane derivative
10/23/2003US20030199483 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of pathogenic conditions
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198601 Dry powder drug; aerosol administering
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481391A1 Preventives/remedies for hotflash
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2478392A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1353938A1 Androgenic 7-substituted 11-halogenated steroids
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353683A2 Ghrelin analogs
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353648A2 Microparticles of biodegradable polymer encapsulating a biologically active substance
10/22/2003EP1150661B1 Topical sprays comprising a film forming composition
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1451010A Benzosulfones with calcium antagonist activity
10/22/2003CN1450907A Beta glycan as an inhibin receptor and uses thereof
10/22/2003CN1449819A Weishengli oral liquid medicine and preparation process thereof
10/22/2003CN1125077C Sulphamate derivatives of 1,3,5(10)-estratriene derivatives methods of producing them and pharmaceutical compounds containing them
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1124843C Stable glassy state powder formulations
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
10/21/2003US6635680 Controlled release pellet formulation
10/21/2003US6635672 Agent for lowering prolactin
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635479 Hypothalamus-specific polypeptides
10/21/2003US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders
10/21/2003US6635247 Administering neurotoxin
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084963A1 Non-steroidal progesterone receptor modulators
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084521A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003059282A3 Human monoclonal antibodies against cd30
10/16/2003WO2003048772A3 Detection d'autoanticorps reactifs aux molecules antigenes d'ilots pancreatiques et/ou a l'insuline Detection of autoantibodies reactive molecules to antigens of pancreatic islets and / or insulin
10/16/2003WO2003047504A3 Prevention and treatment of androgen-deprivation induced osteoporosis
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003024993A3 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2002055086A3 Hormone replacement therapy method and its administration form
10/16/2003WO2002054064A3 Method for screening for progesterone receptor isoform-specific ligands
10/16/2003WO2002036151A3 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
10/16/2003WO2002007673A3 Calcilytic compounds
10/16/2003WO2002003978A3 A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195177 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
10/16/2003US20030195157 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194719 Tpst-assay for diagnosis of autism and related disorders
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481976A1 Novel thyroid receptor ligands
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2481028A1 Hormone replacement therapy
10/16/2003CA2480818A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/15/2003EP1352062A2 Improved growth hormone molecules
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351683A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2003EP1351673A1 Compositions of stable t 3? and methods of use thereof
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1244427B1 Pharmaceutical compositions for oral administration
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds
10/15/2003CN1124282C Conformationally constrained backbone cyclized somatostatin analogs
10/14/2003US6632962 Caspase inhibitors and uses thereof
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 290